Despite its best efforts, medical device maker C.R. Bard (NYSE:BCR) wasn’t able to reverse a $2 million bellwether jury verdict finding the company’s troubled Avaulta transvaginal mesh was defective and responsible for harming a patient.
Product Liability
Medtronic can’t shake negligence lawsuit over Transvene defibrillator lead
First bellwether date set for Boston Scientific in pelvic mesh lawsuits
The 1st bellwether trial in the multi-district litigation filed over Boston Scientific‘s (NYSE:BSX) pelvic mesh products is slated for early next year, a federal judge ordered this week.
Johnson & Johnson settles DePuy ASR bellwether ahead of trial
Pelvic mesh makers look to settle lawsuits
Five medical device companies that make pelvic mesh implants are hoping to negotiate settlements for the more than 30,000 pending lawsuits they’re facing in the U.S., anonymous sources told Bloomberg.
Stryker, Medtronic lose preemption bids in OP-1, Calstrux and Infuse lawsuit
A California state court ruled out a series of motions seeking to dismiss a lawsuit filed over bone proteins made by Stryker and Medtronic, ruling that federal law does not preempt the case from going forward.
DePuy ASR bellwether trial delayed again
Pelvic mesh: Bard reportedly settles another Avaulta case
Medtronic wants Arizona judge to reconsider Infuse ruling
Judge delays 1st bellwether DePuy ASR trial
A federal judge delayed the 1st bellwether trial in the multi-district litigation over the DePuy ASR metal-on-metal hip implant, originally slated to begin this week.